Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Microbot Medical (MBOT) Depreciation & Amortization (CF) (2016)

Microbot Medical's Depreciation & Amortization (CF) history spans 7 years, with the latest figure at $2000.0 for Q4 2016.

  • For the quarter ending Q4 2016, Depreciation & Amortization (CF) fell 99.3% year-over-year to $2000.0, compared with a TTM value of $459616.0 through Dec 2016, down 59.17%, and an annual FY2025 reading of $47000.0, down 48.35% over the prior year.
  • Depreciation & Amortization (CF) for Q4 2016 was $2000.0 at Microbot Medical, down from $180619.0 in the prior quarter.
  • The five-year high for Depreciation & Amortization (CF) was $335855.0 in Q1 2014, with the low at $2000.0 in Q4 2016.
  • Average Depreciation & Amortization (CF) over 5 years is $260155.8, with a median of $271397.0 recorded in 2012.
  • Year-over-year, Depreciation & Amortization (CF) surged 44.7% in 2014 and then tumbled 99.3% in 2016.
  • Tracing MBOT's Depreciation & Amortization (CF) over 5 years: stood at $232194.0 in 2012, then soared by 41.36% to $328221.0 in 2013, then fell by 4.15% to $314591.0 in 2014, then decreased by 9.35% to $285163.0 in 2015, then tumbled by 99.3% to $2000.0 in 2016.
  • Per Business Quant, the three most recent readings for MBOT's Depreciation & Amortization (CF) are $2000.0 (Q4 2016), $180619.0 (Q2 2016), and $276997.0 (Q1 2016).